Tenet Q2 net income $826M, EPS $9.84; raises FY2026 EBITDA guidance to $4.83-5.03B

TENET HEALTHCARE CORP

Net income $826M ($9.84 diluted) vs $288M ($3.14) YoY; adjusted EPS $6.12 vs $4.02, up 52.2%.
Consolidated Adjusted EBITDA $1.304B, up 16.3% YoY; margin 23.2%.
Board authorized $2.0B increase to share repurchase program; $2.13B remaining.
FY2026 Adjusted EBITDA outlook raised to $4.83-5.03B (midpoint +$295M); adjusted FCF outlook $2.725-3.025B.
Hospital EBITDA $762M (18.0% margin) vs $623M (15.6%); Ambulatory EBITDA $542M (39.0% margin).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.